ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+30.34%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$445M
AUM Growth
+$445M
(+57%)
Cap. Flow
+$143M
Cap. Flow
% of AUM
32.1%
Top 10 Holdings %
Top 10 Hldgs %
65.11%
Holding
46
New
9
Increased
18
Reduced
8
Closed
5
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$30.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$19.9M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$17.4M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$16M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12.5M |
Top Sells
Sector Composition
| 1 | Healthcare | 73.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $43.2M | 9.6% | 514,000 +364,000 | +243% | +$30.6M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $35.1M | 7.81% | 4,338,557 +1,213,359 | +39% | +$9.83M |
|
|
CPXX
3
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $33.9M | 7.54% | 1,124,666 -291,591 | -21% | -$8.8M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $33.7M | 7.49% | 432,972 +155,700 | +56% | +$12.1M |
|
|
5
Bristol-Myers Squibb
BMY
$96B
| $32.8M | 7.28% | 445,339 +270,339 | +154% | +$19.9M |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $26.9M | 5.98% | 1,412,190 +257,190 | +22% | +$4.9M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $23.1M | 5.14% | 509,330 +104,010 | +26% | +$4.73M |
|
|
DERM
8
DELISTED
Dermira, Inc.
DERM
| $21.1M | 4.69% | 721,663 +546,663 | +312% | +$16M |
|
9
Amicus Therapeutics
FOLD
$2.34B
| $20.2M | 4.49% | 3,698,665 +274,561 | +8% | +$1.5M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $19.9M | 4.41% | 8,556,957 +7,506,500 | +715% | +$17.4M |
|
|
MDVN
11
DELISTED
MEDIVATION, INC.
MDVN
| $16.9M | 3.75% | 279,700 +9,035 | +3% | +$545K |
|
|
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $16M | 3.55% | 963,646 +755,560 | +363% | +$12.5M |
|
|
AGEN
13
Agenus
AGEN
$133M
| $12.6M | 2.79% | 3,099,838 +698,970 | +29% | +$2.83M |
|
|
RLYP
14
DELISTED
RELYPSA INC COM
RLYP
| $11.3M | 2.52% | +613,300 | New | +$11.3M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $10.7M | 2.38% | +329,500 | New | +$10.7M |
|
|
SRNE
16
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $9.27M | 2.06% | 1,655,274 +509,495 | +44% | +$2.85M |
|
|
TLGT
17
DELISTED
Teligent, Inc
TLGT
| $9.21M | 2.05% | 1,290,000 +365,000 | +39% | +$2.61M |
|
18
Gilead Sciences
GILD
$140B
| $9.05M | 2.01% | 108,500 -66,900 | -38% | -$5.58M |
|
|
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $9.05M | 2.01% | 557,003 +19,526 | +4% | +$317K |
|
20
Vanda Pharmaceuticals
VNDA
$279M
| $7.94M | 1.76% | 709,579 -145,000 | -17% | -$1.62M |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.63M | 1.47% | 1,214,833 -189,222 | -13% | -$1.03M |
|
|
CASC
22
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $5.42M | 1.2% | 5,744,723 +1,675,651 | +41% | +$1.58M |
|
23
Cytokinetics
CYTK
$4.23B
| $4.78M | 1.06% | +503,900 | New | +$4.78M |
|
24
Akebia Therapeutics
AKBA
$833M
| $4.65M | 1.03% | +621,873 | New | +$4.65M |
|
25
Veracyte
VCYT
$2.39B
| $4.62M | 1.03% | 918,556 +188,042 | +26% | +$946K |
|